Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandproteseteamet ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2%   Bankruptcy risk   5.1% 1.8% 1.9% 1.7% 1.4% 1.3% 6.6% 6.5%   Credit score (0-100)   45 73 70 71 77 78 36 37   Credit rating   BBB A A A A A BBB BBB   Credit limit (kDKK)   0.0 0.8 0.5 1.5 9.9 27.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,892 3,412 3,457 3,898 3,046 3,532 0.0 0.0   EBITDA   173 494 429 842 515 813 0.0 0.0   EBIT   75.1 384 315 703 336 604 0.0 0.0   Pre-tax profit (PTP)   25.3 315.4 224.1 637.6 291.4 567.9 0.0 0.0   Net earnings   17.6 246.1 173.6 500.5 226.6 441.2 0.0 0.0   Pre-tax profit without non-rec. items   25.3 315 224 638 291 568 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   289 316 266 379 485 448 0.0 0.0   Shareholders equity total   507 753 816 816 1,043 1,484 1,434 1,434   Interest-bearing liabilities   1,064 326 31.6 0.0 319 139 0.0 0.0   Balance sheet total (assets)   2,587 1,873 1,976 2,158 2,257 2,463 1,434 1,434   Net Debt   1,011 313 -15.2 -91.6 303 121 -544 -544     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,892 3,412 3,457 3,898 3,046 3,532 0.0 0.0   Gross profit growth   0.0% -12.3% 1.3% 12.8% -21.8% 15.9% -100.0% 0.0%   Employees   7 7 6 5 4 5 0 0   Employee growth %   0.0% 0.0% -14.3% -16.7% -20.0% 25.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,587 1,873 1,976 2,158 2,257 2,463 1,434 1,434   Balance sheet change%   0.0% -27.6% 5.5% 9.2% 4.6% 9.1% -41.8% 0.0%   Added value   173.4 494.1 429.3 842.4 475.3 813.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   1,399 -147 -228 -90 -136 -310 -448 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   1.9% 11.2% 9.1% 18.0% 11.0% 17.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.4% 18.0% 16.5% 34.6% 15.8% 27.2% 0.0% 0.0%   ROI %   4.7% 24.8% 25.5% 64.5% 25.8% 37.1% 0.0% 0.0%   ROE %   3.5% 39.1% 22.1% 61.3% 24.4% 34.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   19.6% 40.2% 41.3% 37.8% 46.2% 60.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   582.9% 63.4% -3.5% -10.9% 58.8% 14.9% 0.0% 0.0%   Gearing %   209.9% 43.3% 3.9% 0.0% 30.6% 9.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   11.8% 12.3% 52.4% 487.3% 35.6% 32.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 0.4 0.6 0.7 0.8 1.4 0.0 0.0   Current Ratio   0.6 0.5 0.7 0.7 0.9 1.5 0.0 0.0   Cash and cash equivalent   53.1 13.2 46.8 91.6 16.5 18.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -716.6 -440.9 -272.4 -306.0 -126.4 375.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   25 71 72 168 119 163 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   25 71 72 168 129 163 0 0   EBIT / employee   11 55 53 141 84 121 0 0   Net earnings / employee   3 35 29 100 57 88 0 0